MLTX
MoonLake Immunotherapeutics SEC filings
Every EDGAR filing for MoonLake Immunotherapeutics (MLTX), newest first, with AI summaries and stories.
- Ticker
- MLTX
- CIK
- 1821586
- Sector
- Biotech and pharma
- Latest filing
- Sep 30
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINESCHEDULE 13G/AMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
ROUTINESCHEDULE 13GMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc.
T. Rowe Price Investment Management, Inc., filed by
ROUTINESCHEDULE 13G/AMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
ROUTINES-8MoonLake ImmunotherapeuticsMLTXLIVE ROUTINES-3ASRMoonLake ImmunotherapeuticsMLTXLIVE NOTABLE10-QMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, insider filing for MLTX
Kristian Reich, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, insider filing for MLTX
Kristian Reich, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, insider filing for MLTX
Kristian Reich, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, insider filing for MLTX
Kristian Reich, reporting
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, planned sale of MLTX shares
Kristian Reich, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE da Silva Jorge Santos, insider filing for MLTX
da Silva Jorge Santos, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE da Silva Jorge Santos, insider filing for MLTX
da Silva Jorge Santos, reporting
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE da Silva Jorge Santos, planned sale of MLTX shares
da Silva Jorge Santos, reporting
NOTABLESCHEDULE 13D/AMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE424B5MoonLake ImmunotherapeuticsMLTXLIVE ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Matthias Bodenstedt, insider filing for MLTX
Matthias Bodenstedt, reporting
ROUTINE424B5MoonLake ImmunotherapeuticsMLTXLIVE ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE BIOTECHNOLOGY VALUE FUND L P, insider filing for MLTX
BIOTECHNOLOGY VALUE FUND L P, reporting · BVF PARTNERS L P/IL, reporting · +8 more
ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE 5 insider filings
Ramnik Xavier, insider filing for MLTX
Show all 5
- 4Insider filing for MLTX
- 4Insider filing for MLTX
- 4Insider filing for MLTX
- 4Insider filing for MLTX
- 4Insider filing for MLTX
Ramnik Xavier, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, insider filing for MLTX
Kristian Reich, reporting
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE Kristian Reich, planned sale of MLTX shares
Kristian Reich, reporting
ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINESCHEDULE 13G/AMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Matthias Bodenstedt, insider filing for MLTX
Matthias Bodenstedt, reporting
NOTABLE10-QMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINEDEFA14AMoonLake ImmunotherapeuticsMLTXLIVE ROUTINEARSMoonLake ImmunotherapeuticsMLTXLIVE ROUTINEDEF 14AMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Matthias Bodenstedt, insider filing for MLTX
Matthias Bodenstedt, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE da Silva Jorge Santos, insider filing for MLTX
da Silva Jorge Santos, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE Matthias Bodenstedt, insider filing for MLTX
Matthias Bodenstedt, reporting
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE da Silva Jorge Santos, planned sale of MLTX shares
da Silva Jorge Santos, reporting
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE Matthias Bodenstedt, planned sale of MLTX shares
Matthias Bodenstedt, reporting
ROUTINE4MoonLake ImmunotherapeuticsMLTXLIVE BIOTECHNOLOGY VALUE FUND L P, insider filing for MLTX
BIOTECHNOLOGY VALUE FUND L P, reporting · BVF PARTNERS L P/IL, reporting · +8 more
NOTABLESCHEDULE 13D/AMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)
BIOTECHNOLOGY VALUE FUND L P, filed by
ROUTINE144MoonLake ImmunotherapeuticsMLTXLIVE BVF PARTNERS L P/IL, planned sale of MLTX shares
BVF PARTNERS L P/IL, reporting
NOTABLE10-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINE8-KMoonLake ImmunotherapeuticsMLTXLIVE ROUTINESCHEDULE 13GMoonLake ImmunotherapeuticsMLTXLIVE Ownership stake disclosure by Cormorant Asset Management, LP
Cormorant Asset Management, LP, filed by